首页> 外国专利> Bacterial carboxypeptidase cpg2 variants and their use in gene directed enzyme prodrug therapy

Bacterial carboxypeptidase cpg2 variants and their use in gene directed enzyme prodrug therapy

机译：细菌羧肽酶cpg2变体及其在基因定向酶前药治疗中的应用

页面导航

摘要
著录项
相似文献

摘要

The present invention relates to bacterial carboxypeptidases for use in gene directed prodrug therapy, in particular for use in the treatment of disease, including tumors. Specifically, the invention relates to modified bacterial carboxypeptidases which have enhanced catalytic activity.

机译：本发明涉及用于基因定向前药治疗的细菌羧肽酶，特别是用于治疗包括肿瘤在内的疾病。具体地，本发明涉及具有增强的催化活性的修饰的细菌羧肽酶。

著录项

公开/公告号US2004014187A1

专利类型
公开/公告日2004-01-22

原文格式PDF
申请/专利权人 SPRINGER CAROLINE JOY;MARAIS RICHARD MALCOLM;SPOONER ROBERT;
展开▼

申请/专利号US20030275580
发明设计人 CAROLINE JOY SPRINGER;RICHARD MALCOLM MARAIS;ROBERT SPOONER;
展开▼

申请日2003-06-09
分类号C12N9/48;
国家 US
入库时间 2022-08-21 23:18:10

相似文献

专利
外文文献
中文文献